Latest Breaking News On - Clinical stage - Page 4 : comparemela.com

Targeting Treatment Resistance in Chronic Lymphocytic Leukemia

New research has identified a next-generation BTK degrader that could help overcome treatment resistance in CLL and related blood cancers.

United statesOmar abdel wahabJustin taylorAlvaro alencarSkye montoyaAmerican cancer societySylvester comprehensive cancer centerMemorial sloan kettering cancer centerUniversity of miami miller school medicineAmerican society of hematologyMiami miller schoolAmerican cancerNurix therapeuticsAmerican societyKinase impairedAre susceptible

TLC to Present at the 42nd Annual JP Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Dec. 27, 2023 (GLOBE NEWSWIRE) TLC BioSciences (TLC), a late clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical needs in orthopedic disorders, today announced that the company will present at the 42nd Annual JP Morgan Healthcare Conference at 2:00pm PT on Tuesday, January 9, 2024. As a part of the APAC track, TLC will present at the Golden Gate Ballroom at the Marriott Marquis, 780 Mis

T ai peiSan franciscoUnited statesMarriott marquisContact dawn chi corporate communicationsHealthcare conferenceGolden gate ballroomContact dawn chiCorporate communicationsJp morgan healthcare conferencePharmaceutical companyCompany websiteClinical stageSouth san franciscoMarriott marquis

Noveome Biotherapeutics, Inc Receives FDA Notification to Proceed with its Phase 1-2 Clinical Trial in Treatment of NEC

Noveome Biotherapeutics, Inc Receives FDA Notification to Proceed with its Phase 1-2 Clinical Trial in Treatment of NEC
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

United statesGretchen kraemerNoveome biotherapeuticsPatrick welchKarin potokaDrug administrationNoveome biotherapeutics incClinical stageChief medicalTrial evaluatingNecrotizing enterocolitisRare pediatric disease designationOrphan drug designationInvestigational new drugChief medical officerNeonatal intensive care unit

Ractigen Therapeutics Advances into Clinical Stage with Groundbreaking saRNA Drug, RAG-01

Ractigen Therapeutics Advances into Clinical Stage with Groundbreaking saRNA Drug, RAG-01
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Cheng liTherapeutics advancesClinical stageBacillus calmette guRactigen therapeutics

Processa Pharmaceuticals Issues Letter to Shareholders

HANOVER, MD, Nov. 29, 2023 (GLOBE NEWSWIRE) Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage.

Processa ngcsBret shapiroPatrick linDear processa pharmaceuticals shareholdersStraits researchProcessa pharmaceuticalsOptimus oncology initiativeCompany contactStable financial affairsProcessa pharmaceuticals incCompany next generation chemotherapyProcessa teamPharmaceuticals incBusiness development opportunitiesProcessa pharmaceuticals shareholdersRegulatory science approach